'Covidization' Of Resources Brings Huge Disruption For TB Patients, Researchers

Redirection of healthcare resources to tackle COVID-19 is posing huge challenges for TB care and researchers in the area. Companies like J&J have stepped in to support, among other aspects, innovative community-based solutions to ensure continuity of care for drug resistant-TB patients amid the pandemic.

Tuberculosis
TB Patients, Researchers Face Challenges As Resources Redirected To COVID-19 • Source: Shutterstock

Tuberculosis, the world's top infectious disease, never really received priority in funding or R&D over the years and “covidization” of all major aspects in the healthcare sector has now diverted the focus further away from TB, amplifying challenges and threatening to undo years of progress in the segment.

Dr Madhukar Pai, Canada Research Chair in Translational Epidemiology and Global Health and Director at the McGill International TB Centre,...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from COVID-19

More from Scrip